AnaptysBio
ANAB
ANAB
129 hedge funds and large institutions have $2.85B invested in AnaptysBio in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more funds holding
Funds holding: 124 → 129 (+5)
2.71% more ownership
Funds ownership: 105.96% → 108.67% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
129
Holding in Top 10
3
Calls
$88.8M
Puts
$37.7M
Top Buyers
| 1 | +$91.4M | |
| 2 | +$41M | |
| 3 | +$39.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$31.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.8M |
Top Sellers
| 1 | -$24.8M | |
| 2 | -$19.4M | |
| 3 | -$18.2M | |
| 4 |
Millennium Management
New York
|
-$14.3M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.82M |